MyAverix Finance
SA · Healthcare
Gilead Sciences Inc (GILD34)
Drug Manufacturers - General
Gilead Sciences Inc (GILD34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-29, reported market cap is $906.82B, P/E ratio is 20.58, net margin is 28.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GILD34
Gilead Sciences Inc (GILD34) — FAQ
What is Gilead Sciences Inc's market cap?
Gilead Sciences Inc (GILD34) has a reported market cap of $906.82B (data as of 2026-03-29).
What is GILD34's P/E ratio?
The price-to-earnings (P/E) ratio for Gilead Sciences Inc (GILD34) is 20.58 (data as of 2026-03-29).
Does Gilead Sciences Inc pay a dividend?
Dividend yield is not available in the current snapshot for Gilead Sciences Inc (GILD34). Check the MyAverix Finance app for the latest dividend data.
What sector is Gilead Sciences Inc in?
Gilead Sciences Inc (GILD34) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is GILD34 listed on?
GILD34 is listed on SA.
What is Gilead Sciences Inc's net margin?
Gilead Sciences Inc (GILD34) reports a net margin of 28.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.